A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans
about
A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid AddictionDiscontinuation of buprenorphine maintenance therapy: perspectives and outcomesBuprenorphine Treatment for Probationers and Parolees.Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status.Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study.Changes in Quality of Life following Buprenorphine Treatment: Relationship with Treatment Retention and Illicit Opioid Use.Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy.Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research.Buprenorphine Treatment and 12-step Meeting Attendance: Conflicts, Compatibilities, and Patient Outcomes.Prior Experience with Non-Prescribed Buprenorphine: Role in Treatment Entry and Retention.Retention in methadone and buprenorphine treatment among African Americans.Two Models of Integrating Buprenorphine Treatment and Medical Staff within Formerly "Drug-Free" Outpatient Programs.Leaving buprenorphine treatment: patients' reasons for cessation of care.Retention in medication-assisted treatment for opiate dependence: A systematic review.Three-year retention in buprenorphine treatment for opioid use disorder nationally in the Veterans Health Administration.Update on pharmacotherapy for treatment of opioid use disorder.Treatment outcomes among a cohort of African American buprenorphine patients: Follow-up at 12 months
P2860
Q28069995-8534E160-AC9A-4196-9750-1FCF97832C92Q28082657-476065BB-D6C8-4E87-BCB7-5DE63D12E965Q34289480-4E2488CB-9FBB-4236-87AC-AF83E72656E0Q34425700-8F96BB73-B463-4AA7-B351-DF682A428F99Q34452695-DA53AE41-23E4-4DAC-B550-633258DBBB30Q35586209-C434413C-3786-46B3-9B9C-894BD96622C0Q35901215-B41FD43E-2B41-48BA-85EC-CD807E080E65Q35998254-D6E8BB6F-CA35-4555-9EC0-B8EB61813D9DQ36030715-99B68551-A1D8-4BA0-AE1A-07BD81A014FAQ36030969-718BB71B-8949-4D99-AFCC-98BFE875090EQ37022122-B8AC6C12-71CA-439F-B4D4-AC0BF838C176Q37115985-E63CE909-BA6D-4884-8BF2-0A25C4DBD0ADQ37625625-05CCEA15-AA44-4506-85C5-7F2A53E006DAQ38607448-ED81206A-E51B-4396-A869-9D729B31AA40Q38687655-3B955F81-8838-4CBB-874F-698F4CCAA368Q38979423-77CDCA5D-F889-42A7-9B87-6C58A613CF8EQ58275852-292827F2-1CB1-4CCC-8A25-B1334FCD93B0
P2860
A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A randomized trial of intensiv ...... reatment for African Americans
@ast
A randomized trial of intensiv ...... reatment for African Americans
@en
type
label
A randomized trial of intensiv ...... reatment for African Americans
@ast
A randomized trial of intensiv ...... reatment for African Americans
@en
prefLabel
A randomized trial of intensiv ...... reatment for African Americans
@ast
A randomized trial of intensiv ...... reatment for African Americans
@en
P2093
P2860
P1476
A randomized trial of intensiv ...... reatment for African Americans
@en
P2093
Jan Gryczynski
Jerome H Jaffe
Kevin E O'Grady
Robert P Schwartz
Shannon Gwin Mitchell
Yngvild K Olsen
P2860
P304
P356
10.1016/J.DRUGALCDEP.2012.08.027
P577
2012-09-20T00:00:00Z